Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study

BACKGROUND: The long-acting injectable antipsychotic aripiprazole once-monthly 400 mg (AOM 400) was recently approved for maintenance treatment of bipolar I disorder (BP-I). The purpose of this study was to evaluate the safety, tolerability, and efficacy of AOM 400 as long-term maintenance treatment...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Bipolar Disord
Main Authors: Calabrese, Joseph R., Jin, Na, Johnson, Brian, Such, Pedro, Baker, Ross A., Madera, Jessica, Hertel, Peter, Ottinger, Jocelyn, Amatniek, Joan, Kawasaki, Hiroaki
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2018
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6162003/
https://ncbi.nlm.nih.gov/pubmed/29886522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40345-018-0122-z
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki